Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer

Josephine A. Hinneh(South Australian Health and Medical Research Institute), Lisa M. Butler(South Australian Health and Medical Research Institute)

British Journal of Cancer

September 6, 2023

10.1038/s41416-023-02406-8

Cited by 13

Related Papers

ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer

|Cancer Research|2021|94

A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth

|eLife|2021|36

IκBα mediates prostate cancer cell death induced by combinatorial targeting of the androgen receptor

|BMC Cancer|2016|10